Lipella Pharmaceuticals Inc. Accounts Payable
Lipella Pharmaceuticals Inc. (LIPO) had Accounts Payable of $462.89 thousand as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-11-14
- 2025-09-30: Accounts Payable, Current $462.89K.
- 2025-06-30: Accounts Payable, Current $608.11K.
- 2025-03-31: Accounts Payable, Current $392.12K.
- 2024-12-31: Accounts Payable, Current $388.19K.
| Period end | Accounts Payable, Current |
|---|---|
| 2025-09-30 | $462.89K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $608.11K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $392.12K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $388.19K 10-Q · filed 2025-11-14 |
| 2024-09-30 | $459.45K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $178.36K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $293.83K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $138.02K 10-K · filed 2025-03-28 |
| 2023-09-30 | $303.05K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $22.06K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $148.92K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $384.36K 10-K · filed 2024-02-27 |
| 2021-12-31 | $46.90K 10-K · filed 2023-03-31 |